Topic 18 of 20
Opinion Health Economics Cash shortages and access to acute-care medicines: evidence from demonetisation and the case for a health protocol in currency operations

Liquidity Is Health Policy: Every Future Currency Operation Needs a Medicine Protocol

Source The Hindu, Wiley Online Library, RBI, Journal of Political Economy, Indian Kanoon, PIB, Jan Aushadhi, Al Jazeera

86 per cent of India's currency by value was withdrawn on four hours' notice on 8 November 2016. New research finds that in the weeks that followed, purchases of medicines for sudden illnesses fell about 3.6 per cent relative to medicines for chronic conditions: a measurable dent in health from a monetary decision.

Summary

In an op-ed marking ten years since demonetisation, economists Anindya Chakrabarti, Chirantan Chatterjee and Samarth Gupta summarise their research, forthcoming in the Journal of Economics and Management Strategy. Using All India Organisation of Chemists and Druggists data covering 805 pharmaceutical firms, 31 regions and 18 illness categories, they find that sales of acute-care drugs fell about 3.6 per cent in volume and 3.1 per cent in value relative to chronic-care drugs after the cash shock.

Prices and product variety did not change and prescription and disease-outbreak data showed no break, pointing to a pure fall in purchases. Declines were larger where primary health infrastructure was weaker. The authors argue that future currency operations need a health-sector protocol.

WHY IT MATTERS FOR UPSC & STATE PCS

On the tenth anniversary of demonetisation, new research has shown that the 2016 cash shortage reduced purchases of essential acute-care medicines, especially where public health infrastructure was thin, raising questions about how macroeconomic shocks affect health.

Standard News

Cash Is a Health Input and Policy Should Treat It That Way

TAN's position is simple: in an economy where people still pay for medicine out of pocket, cash is a health input. Any future large currency operation should therefore come with a health-sector protocol, planned in advance.

The reasoning The evidence comes from a careful study.

Economists Anindya Chakrabarti, Chirantan Chatterjee and Samarth Gupta used pharmacy sales data from the All India Organisation of Chemists and Druggists, covering 805 firms, 31 regions and 18 illness categories. They compared two kinds of medicines:

  • Chronic-care drugs, such as those for diabetes or blood pressure, are bought every month. Families plan for them and can shop around.
  • Acute-care drugs, such as antibiotics or painkillers, are bought suddenly when someone falls ill. There is little time to search for a cheaper option and if cash is short, the purchase is the first to be postponed. After demonetisation, acute-drug sales fell about 3.6 per cent in volume and 3.1 per cent in value relative to chronic drugs. Prices and the range of products did not change and prescription and disease-outbreak data showed no break, so this was not a shift in illness or doctors' behaviour. People simply bought less of the medicine they needed suddenly. The declines were sharpest in November and December 2016 and larger where primary health centres were thinner. The logic follows. If a cash shock reduces essential purchases and the effect is worst where public health support is weakest, then the cost falls on those least able to bear it. In 2021-22, out-of-pocket spending was still 39.4 per cent of total health expenditure. Any plan that withdraws cash must account for that.

The strongest counter-argument Demonetisation's defenders have a serious case.

Its stated aims were to curb black money and counterfeit notes and to push digital payments. Research by Crouzet and colleagues shows it permanently accelerated digital payment adoption. In 2023, a Constitution Bench of the Supreme Court upheld it by a 4:1 majority, finding the decision-making lawful and the measure proportionate.

The court held that hardship to citizens does not by itself make a legitimate policy unconstitutional. Seen this way, a 3.6 per cent relative fall in acute-drug purchases for a few months is a temporary cost of a structural shift that made later disruptions easier to absorb.

Why the

position still holds That argument proves the policy could be lawful and could have long-term benefits. It does not prove that its health costs were unavoidable. TAN does not dispute demonetisation's intent. The point is narrower: even a lawful, well-intentioned measure can carry hidden harms that simple planning could reduce.

Since 2016, India has built the tools to do this: over 11,000 Jan Aushadhi Kendras, Ayushman Bharat PM-JAY and UPI payments at pharmacies. A health protocol would use them. Credit lines for pharmacies, digital-payment support at the point of sale and pre-registered evaluation of effects would protect people who cannot postpone falling ill.

Nigeria's 2022-23 currency redesign, which led to reports of patients being turned away for lack of cash, shows the cost of not planning.

Quick Facts

Key numbers & takeaways — revise these first

  • On 8 November 2016, about 86 per cent of India's currency by value was demonetised at four hours' notice.

  • The RBI reported that about 99.3 per cent of demonetised notes returned to the banking system.

  • The study used AIOCD data on 805 pharmaceutical firms, 31 regions and 18 illness categories.

  • Acute-care drug sales fell about 3.6 per cent in volume and 3.1 per cent in value relative to chronic-care drugs.

  • The steepest declines came in November and December 2016.

  • Out-of-pocket health spending was 39.4 per cent of total health expenditure in 2021-22.

  • India had over 11,000 Jan Aushadhi Kendras as of March 2026.

  • In Vivek Narayan Sharma v. Union of India (2023), the Supreme Court upheld demonetisation by a 4:1 majority.

  • Section 26(2) of the RBI Act, 1934 was the legal basis for demonetisation.

  • Nigeria and Kenya also experienced cash shortages after currency withdrawals, in 2022-23 and 2019 respectively.

Beyond The Headlines
Opinion Cash shortages and access to acute-care medicines: evidence from demonetisation and the case for a health protocol in currency operations

Connect the dots for your UPSC preparation.

Standard news covers the event. Log in to read our comprehensive analysis and uncover the hidden constitutional, structural, and ethical dimensions of this topic:

1

How the comparison between acute and chronic drugs isolates the effect of the cash shortage from changes in disease or prescribing

2

The full case for demonetisation, including digital adoption and the 2023 Constitution Bench reasoning, built at full strength

3

Why denser primary health centres cushioned the shock and what that means for health planning

4

A concrete protocol for future currency operations, from pharmacy credit lines to pre-registered evaluation

Included in this analysis

Deep Analysis Sharpens your Mains-level understanding.
8 Languages Read the news comfortably in your language.
PYQ Connection Direct connection with previous year Mains questions.
Expected Questions Possible upcoming questions for Prelims & Mains.
Daily Evaluation Daily Prelims test, plus category-wise Mains evaluation.
Mentor Observation Daily, topic-wise expert feedback on your tests.
Value Additions Important Case Studies and daily Vocab Word.

Join thousands of aspirants analyzing the news deeply.

Unlock Premium — Rs.699 Annually
FOUNDATION MEMBER PRICE
₹6,999 ₹699 Annually

From Year 2: only ₹399/month for Foundation Members

More from 09 Nov 2026

Short titles by category — open any story to read it fully.